Abstractive Health vs MedScrub
Two answers to the same governance objection about sending records to a model. Abstractive answers it with paperwork and evidence: a typed attestation, a public trust centre, a published business associate agreement and a peer reviewed evaluation of its own summaries that reported them as marginally inferior to physicians. MedScrub answers it architecturally, stripping the patient out before anything reaches a model, letting the customer choose which model runs and re identifying on return. If your blocker is contractual, Abstractive has already published the documents. If it is that no external model should ever see identified data, MedScrub removes the exposure rather than governing it, and accepts a residual re identification risk in free text that no contract can eliminate.
- It published its own evaluation in a peer reviewed journal with a result unfavourable to the product, and links every sentence of a summary to its source note.
- The compliance position is complete and inspectable, with a typed attestation, public trust centre, published business associate agreement and published price ladder.
- It is a direct implementer on the national exchange framework rather than a consumer of someone else's connection.
- The patient is stripped out before anything reaches a model and re identified on the way back, so the model provider never sees identified data.
- The customer chooses which model runs, which answers the provenance question completely rather than asking a buyer to trust the vendor's choice.
- For an organisation whose legal team has blocked sending records to an external model, this removes the blocker rather than papering over it.
Side by Side
| Axis | A Abstractive Health |
M MedScrub |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.
The privacy architectures differ in kind: one contracts for the handling of identified data with published terms, the other removes identified data from the path and accepts residual re identification risk in free clinical text, which cannot be contracted away. MedScrub describes no oversight mechanism for the clinical output, no confidence signal and no abstention behaviour, which is a notable gap beside an otherwise exceptional design. Neither publishes an omission rate, which is the decisive failure in summarisation because a summary that drops the one relevant record looks complete.